Evercore Wealth Management, LLC - CANTEL MEDICAL CORP ownership

CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 232 filers reported holding CANTEL MEDICAL CORP in Q4 2020. The put-call ratio across all filers is 1.87 and the average weighting 0.3%.

Quarter-by-quarter ownership
Evercore Wealth Management, LLC ownership history of CANTEL MEDICAL CORP
ValueSharesWeighting
Q1 2021$256,000
-76.3%
3,205
-76.5%
0.01%
-78.3%
Q4 2020$1,078,000
+87.8%
13,664
+4.6%
0.02%
+64.3%
Q3 2020$574,000
-2.0%
13,069
-1.4%
0.01%
-12.5%
Q2 2020$586,000
+21.3%
13,249
-1.6%
0.02%0.0%
Q1 2020$483,000
-50.6%
13,463
-2.4%
0.02%
-38.5%
Q4 2019$978,000
-5.8%
13,800
-0.5%
0.03%
-13.3%
Q3 2019$1,038,000
+1.1%
13,872
+8.9%
0.03%
-3.2%
Q2 2019$1,027,000
+20.5%
12,7390.0%0.03%
+14.8%
Q1 2019$852,000
-11.1%
12,739
-0.9%
0.03%
-25.0%
Q4 2018$958,000
-16.8%
12,861
+2.8%
0.04%
-2.7%
Q3 2018$1,151,000
-8.7%
12,508
-2.4%
0.04%
-14.0%
Q2 2018$1,260,000
-13.4%
12,810
-1.9%
0.04%
-23.2%
Q1 2018$1,455,000
-0.7%
13,064
-8.3%
0.06%
+3.7%
Q4 2017$1,465,000
-2.7%
14,243
-10.9%
0.05%
-8.5%
Q3 2017$1,506,000
+20.9%
15,9910.0%0.06%
+22.9%
Q2 2017$1,246,000
-27.6%
15,991
-25.5%
0.05%
-28.4%
Q1 2017$1,720,000
+1.4%
21,471
-0.3%
0.07%
-4.3%
Q4 2016$1,696,000
+0.7%
21,536
-0.3%
0.07%0.0%
Q3 2016$1,684,000
+13.4%
21,6000.0%0.07%
+6.1%
Q2 2016$1,485,000
-4.3%
21,600
-0.7%
0.07%
-4.3%
Q1 2016$1,552,000
+14.4%
21,748
-0.4%
0.07%
+9.5%
Q4 2015$1,357,000
+9.6%
21,8350.0%0.06%
+6.8%
Q3 2015$1,238,000
+3.9%
21,835
-1.7%
0.06%
+9.3%
Q2 2015$1,192,000
+13.0%
22,2110.0%0.05%
+12.5%
Q1 2015$1,055,000
+9.8%
22,2110.0%0.05%0.0%
Q4 2014$961,000
+25.8%
22,2110.0%0.05%
+26.3%
Q3 2014$764,000
-6.0%
22,2110.0%0.04%
-9.5%
Q2 2014$813,000
+8.5%
22,2110.0%0.04%0.0%
Q1 2014$749,000
-2.6%
22,211
-2.0%
0.04%0.0%
Q4 2013$769,000
+6.5%
22,6650.0%0.04%
+2.4%
Q3 2013$722,000
+41.0%
22,665
+50.0%
0.04%
+41.4%
Q2 2013$512,00015,1100.03%
Other shareholders
CANTEL MEDICAL CORP shareholders Q4 2020
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of CANTEL MEDICAL CORP shareholders